Xia Li

Xia (Shelly) Li is a Senior Director of Biostatistics in Late Oncology at AstraZeneca, where they lead a team of clinical statisticians responsible for developing statistical strategies for late-phase Immuno-Oncology bispecific assets. Prior to this role, Xia served as an Associate Director and Principal Statistician at AstraZeneca, contributing as a statistical lead for LUMOXITI® BLA and supporting IMFINZI® BLA. Their earlier experience includes positions as a Research Statistician and later as a Manager/Senior Research Statistician in Oncology at AbbVie. Xia is currently pursuing a PhD in Statistics at the University of Cincinnati while holding a B.S. in Applied Mathematics from the South China University of Technology.